Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
Protomer's proprietary peptide- and protein-engineering platform is used to identify and synthesize molecules that can sense glucose or other endogenous modulators of protein activity.
Lead Product(s): Glucose Responsive Insulin
Therapeutic Area: Endocrinology Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Peptide
Partner/Sponsor/Collaborator: Eli Lilly
Deal Size: $1,000.0 million Upfront Cash: Undisclosed
Deal Type: Acquisition July 14, 2021